CoChat

Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial

Open access
Kario, Kazuomi, Yokoi, Yoshiaki, Okamura, Keisuke, Fujihara, Masahiko, Ogoyama, Yukako, Yamamoto, Eiichiro, Urata, Hidenori, Cho, Jin-Man, Kim, Chong-Jin, Choi, Seung-Hyuk, Shinohara, Keisuke, Mukai, Yasushi, Ikemoto, Tomokazu, Nakamura, Masato, Seki, Shuichi, Matoba, Satoaki, Shibata, Yoshisato, Sugawara, Shigeo, Yumoto, Kazuhiko, Tamura, Kouichi, Yoshihara, Fumiki, Nakamura, Satoko, Kang, Woong Chol, Shibasaki, Taro, Dote, Keigo, Yokoi, Hiroyoshi, Matsuo, Akiko, Fujita, Hiroshi, Takahashi, Toshiyuki, Kang, Hyun-Jae, Sakata, Yasushi, Horie, Kazunori, Inoue, Naoto, Sasaki, Ken-ichiro, Ueno, Takafumi, Tomita, Hirofumi, Morino, Yoshihiro, Nojima, Yuhei, Kim, Chan Joon, Matsumoto, Tomoaki, Kai, Hisashi, Nanto, Shinsuke · 2022 · Hypertension Research
Cited by 143

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Renal denervation is a promising new non-pharmacological treatment for resistant hypertension. However, there is a lack of data from Asian patients. The REQUIRE trial investigated the blood pressure-lowering efficacy of renal denervation in treated patients with resistant hypertension from Japan and South Korea. Adults with resistant hypertension (seated office blood pressure ≥150/90 mmHg and 24-hour ambulatory systolic blood pressure ≥140 mmHg) with suitable renal artery anatomy were randomized to ultrasound renal denervation or a sham procedure. The primary endpoint was change from baseline in 24-hour ambulatory systolic blood pressure at 3 months. A total of 143 patients were included (72 renal denervation, 71 sham control). Reduction from baseline in 24-hour ambulatory systolic blood pressure at 3 months was not significantly different between the renal denervation (−6.6 mmHg) and sham control (−6.5 mmHg) groups (difference: −0.1, 95% confidence interval −5.5, 5.3; p = 0.971). Reductions from baseline in home and office systolic blood pressure (differences: –1.8 mmHg [p = 0.488] and −2.0 mmHg [p = 0.511], respectively), and medication load, did not differ significantly between the two groups. The procedure-/device-related major adverse events was not seen. This study did not show a significant difference in ambulatory blood pressure reductions between renal denervation and a sham procedure in treated patients with resistant hypertension. Although blood pressure reduction after renal denervation was similar to other sham-controlled studies, the sham group in this study showed much greater reduction. This unexpected blood pressure reduction in the sham control group highlights study design issues that will be addressed in a new trial. Clinical trial registration: NCT02918305 (http://www.clinicaltrials.gov).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41440-021-00754-7

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 143

Metadata

Authors
Kario, K., Yokoi, Y., Okamura, K., Fujihara, M., Ogoyama, Y., Yamamoto, E., Urata, H., Cho, J.-M., Kim, C.-J., Choi, S.-H., Shinohara, K., Mukai, Y., Ikemoto, T., Nakamura, M., Seki, S., Matoba, S., Shibata, Y., Sugawara, S., Yumoto, K., Tamura, K., Yoshihara, F., Nakamura, S., Kang, W. C., Shibasaki, T., Dote, K., Yokoi, H., Matsuo, A., Fujita, H., Takahashi, T., Kang, H.-J., Sakata, Y., Horie, K., Inoue, N., Sasaki, K.-I., Ueno, T., Tomita, H., Morino, Y., Nojima, Y., Kim, C. J., Matsumoto, T., Kai, H., & Nanto, S.
Venue
Hypertension Research
Published
2021-10-15
Volume
45
Issue
2
Pages
221-231
ISSN
  • 0916-9636 (ISSN-L)
  • 1348-4214
OpenAlex
W3206798051
Cited by
143
References
10
FWCI
16.65
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial. https://app.cochat.ai/papers/10.1038/s41440-021-00754-7
The paper
Kario, K., Yokoi, Y., Okamura, K., Fujihara, M., Ogoyama, Y., Yamamoto, E., Urata, H., Cho, J.-M., Kim, C.-J., Choi, S.-H., Shinohara, K., Mukai, Y., Ikemoto, T., Nakamura, M., Seki, S., Matoba, S., Shibata, Y., Sugawara, S., Yumoto, K., . . . Nanto, S. (2022). Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial. Hypertension Research. https://doi.org/10.1038/s41440-021-00754-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.